These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 12105842)

  • 1. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.
    Bugianesi E; Leone N; Vanni E; Marchesini G; Brunello F; Carucci P; Musso A; De Paolis P; Capussotti L; Salizzoni M; Rizzetto M
    Gastroenterology; 2002 Jul; 123(1):134-40. PubMed ID: 12105842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
    Starley BQ; Calcagno CJ; Harrison SA
    Hepatology; 2010 May; 51(5):1820-32. PubMed ID: 20432259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea?].
    Oh KC; Park SH; Park JC; Jin DK; Park CS; Kim KO; Jang HJ; Lee JY; Park CH; Han TH; Yoo KS; Kim JH; Kim DJ; Lee MS; Park CK
    Korean J Gastroenterol; 2005 Jan; 45(1):45-51. PubMed ID: 15665567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
    Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
    Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation and prevalence of spontaneous bacterial peritonitis in patients with cryptogenic cirrhosis and features of metabolic syndrome.
    Sorrentino P; Tarantino G; Conca P; Perrella A; Perrella O
    Can J Gastroenterol; 2004 Jun; 18(6):381-6. PubMed ID: 15190393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.
    Yatsuji S; Hashimoto E; Tobari M; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol Hepatol; 2009 Feb; 24(2):248-54. PubMed ID: 19032450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptogenic cirrhosis in the region where obesity is not prevalent.
    Kojima H; Sakurai S; Matsumura M; Umemoto N; Uemura M; Morimoto H; Tamagawa Y; Fukui H
    World J Gastroenterol; 2006 Apr; 12(13):2080-5. PubMed ID: 16610061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
    Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
    Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.
    Takuma Y; Nouso K; Makino Y; Gotoh T; Toshikuni N; Morimoto Y; Shimomura H; Yamamoto H
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1417-24. PubMed ID: 21884248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of patients with hepatocellular carcinoma (HCC) that developed in cryptogenic cirrhosis suggestive of nonalcoholic steatohepatitis (NASH) as background liver disease after clinical courses of 26 years].
    Tsutsumi K; Nakayama H; Sakai Y; Kojima Y; Dairaku N; Ojima T; Kusano M; Ikeya S; Sugai Y; Hiwatashi N
    Nihon Shokakibyo Gakkai Zasshi; 2007 May; 104(5):690-7. PubMed ID: 17485950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of development of hepatocellular carcinoma in patients with NASH-related cirrhosis.
    Amarapurkar DN; Dharod M; Gautam S; Patel N
    Trop Gastroenterol; 2013; 34(3):159-63. PubMed ID: 24851525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and hepatocellular carcinoma.
    Caldwell SH; Crespo DM; Kang HS; Al-Osaimi AM
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S97-103. PubMed ID: 15508109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for nonalcoholic steatohepatitis in cryptogenic cirrhosis.
    Leite AB; Mattos AA; Mattos AZ; Coral GP; Evaldt S
    Arq Gastroenterol; 2012 Dec; 49(4):245-9. PubMed ID: 23329217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma.
    Lee SS; Jeong SH; Byoun YS; Chung SM; Seong MH; Sohn HR; Min BY; Jang ES; Kim JW; Park GJ; Lee YJ; Lee KH; Ahn S
    BMC Cancer; 2013 Jul; 13():335. PubMed ID: 23829392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
    Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
    Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steatosis and hepatocellular carcinoma risk.
    Smedile A; Bugianesi E
    Eur Rev Med Pharmacol Sci; 2005; 9(5):291-3. PubMed ID: 16231592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
    Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
    Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.
    Rinaldi L; Nascimbeni F; Giordano M; Masetti C; Guerrera B; Amelia A; Fascione MC; Ballestri S; Romagnoli D; Zampino R; Nevola R; Baldelli E; Iuliano N; Rosato V; Lonardo A; Adinolfi LE
    World J Gastroenterol; 2017 Feb; 23(8):1458-1468. PubMed ID: 28293093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C.
    Tokushige K; Hashimoto E; Yatsuji S; Tobari M; Taniai M; Torii N; Shiratori K
    J Gastroenterol; 2010 Sep; 45(9):960-7. PubMed ID: 20376504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is cryptogenic cirrhosis different from NASH cirrhosis?
    Thuluvath PJ; Kantsevoy S; Thuluvath AJ; Savva Y
    J Hepatol; 2018 Mar; 68(3):519-525. PubMed ID: 29162389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.